Trial Profile
A Phase III, Open-label, multicenter, non-comparative 12 month study to evaluate the efficacy and safety of Triptorelin Acetate in children with central precocious puberty
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Apr 2017
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Precocious puberty
- Focus Therapeutic Use
- 28 Apr 2017 New trial record